Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-01-500117
Filing Date
2001-04-16
Accepted
2001-04-16 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 joc16160000ai6.txt SC 13G/A 9373
  Complete submission text file 0000919574-01-500117.txt   11314
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

 

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 100 CORPORATE NORTH STE 215 BANNOCKBURN IL 60015 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49245 | Film No.: 1603273
SIC: 2836 Biological Products, (No Diagnostic Substances)